nodes	percent_of_prediction	percent_of_DWPC	metapath
Baclofen—SLC22A8—Zidovudine—acquired immunodeficiency syndrome	0.293	1	CbGbCtD
Baclofen—GABBR2—spinal cord—acquired immunodeficiency syndrome	0.0124	0.141	CbGeAlD
Baclofen—GABBR2—nervous system—acquired immunodeficiency syndrome	0.0104	0.119	CbGeAlD
Baclofen—GABBR2—central nervous system—acquired immunodeficiency syndrome	0.01	0.115	CbGeAlD
Baclofen—GABBR2—brain—acquired immunodeficiency syndrome	0.00797	0.0909	CbGeAlD
Baclofen—GABBR1—blood—acquired immunodeficiency syndrome	0.00648	0.074	CbGeAlD
Baclofen—GABBR1—bone marrow—acquired immunodeficiency syndrome	0.00627	0.0716	CbGeAlD
Baclofen—GABBR1—spinal cord—acquired immunodeficiency syndrome	0.00624	0.0713	CbGeAlD
Baclofen—GABBR1—vagina—acquired immunodeficiency syndrome	0.00601	0.0686	CbGeAlD
Baclofen—GABBR1—lung—acquired immunodeficiency syndrome	0.00568	0.0648	CbGeAlD
Baclofen—GABBR1—brain—acquired immunodeficiency syndrome	0.00402	0.0459	CbGeAlD
Baclofen—GABBR1—lymph node—acquired immunodeficiency syndrome	0.00389	0.0443	CbGeAlD
Baclofen—GABBR2—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00274	0.0543	CbGpPWpGaD
Baclofen—SLC22A8—blood—acquired immunodeficiency syndrome	0.00256	0.0292	CbGeAlD
Baclofen—SLC22A8—nervous system—acquired immunodeficiency syndrome	0.00208	0.0237	CbGeAlD
Baclofen—SLC22A8—central nervous system—acquired immunodeficiency syndrome	0.002	0.0228	CbGeAlD
Baclofen—GABBR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	0.00177	0.035	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00166	0.0329	CbGpPWpGaD
Baclofen—SLC22A8—brain—acquired immunodeficiency syndrome	0.00159	0.0181	CbGeAlD
Baclofen—GABBR2—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.00153	0.0304	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.0015	0.0298	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00144	0.0286	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00144	0.0286	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00141	0.0279	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.0011	0.0217	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00107	0.0212	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.00103	0.0203	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000989	0.0196	CbGpPWpGaD
Baclofen—GABBR2—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000989	0.0196	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000969	0.0192	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000929	0.0184	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000929	0.0184	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000929	0.0184	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000907	0.018	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000873	0.0173	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000873	0.0173	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000853	0.0169	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000832	0.0165	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000772	0.0153	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000707	0.014	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000664	0.0132	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000662	0.0131	CbGpPWpGaD
Baclofen—GABBR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000637	0.0126	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000599	0.0119	CbGpPWpGaD
Baclofen—GABBR2—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000599	0.0119	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000563	0.0111	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000563	0.0111	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.00055	0.0109	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000536	0.0106	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000527	0.0104	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000525	0.0104	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000504	0.00998	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000504	0.00998	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000497	0.00984	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000494	0.00977	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000494	0.00977	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000477	0.00944	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000456	0.00902	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000448	0.00887	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000448	0.00887	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000428	0.00848	CbGpPWpGaD
Baclofen—GABBR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000386	0.00764	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000375	0.00743	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.00037	0.00732	CbGpPWpGaD
Baclofen—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000343	0.000602	CcSEcCtD
Baclofen—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000342	0.000601	CcSEcCtD
Baclofen—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000342	0.000601	CcSEcCtD
Baclofen—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000341	0.0006	CcSEcCtD
Baclofen—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000341	0.0006	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000341	0.00675	CbGpPWpGaD
Baclofen—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000341	0.000599	CcSEcCtD
Baclofen—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.00034	0.000598	CcSEcCtD
Baclofen—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.00034	0.000597	CcSEcCtD
Baclofen—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.000597	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.00034	0.00673	CbGpPWpGaD
Baclofen—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000339	0.000596	CcSEcCtD
Baclofen—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.000596	CcSEcCtD
Baclofen—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000339	0.000596	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000338	0.0067	CbGpPWpGaD
Baclofen—GABBR2—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000338	0.0067	CbGpPWpGaD
Baclofen—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000338	0.000594	CcSEcCtD
Baclofen—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000338	0.000594	CcSEcCtD
Baclofen—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000338	0.000594	CcSEcCtD
Baclofen—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000337	0.000592	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000337	0.000592	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000336	0.00665	CbGpPWpGaD
Baclofen—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000336	0.00059	CcSEcCtD
Baclofen—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000335	0.000589	CcSEcCtD
Baclofen—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000335	0.000589	CcSEcCtD
Baclofen—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.000335	0.000589	CcSEcCtD
Baclofen—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000335	0.000588	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.000335	0.000588	CcSEcCtD
Baclofen—Pain—Indinavir—acquired immunodeficiency syndrome	0.000332	0.000584	CcSEcCtD
Baclofen—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000332	0.000584	CcSEcCtD
Baclofen—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000332	0.000584	CcSEcCtD
Baclofen—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000332	0.000583	CcSEcCtD
Baclofen—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000332	0.000583	CcSEcCtD
Baclofen—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000332	0.000583	CcSEcCtD
Baclofen—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000331	0.000581	CcSEcCtD
Baclofen—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.000581	CcSEcCtD
Baclofen—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.000581	CcSEcCtD
Baclofen—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.00033	0.00058	CcSEcCtD
Baclofen—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.00033	0.000579	CcSEcCtD
Baclofen—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.00033	0.000579	CcSEcCtD
Baclofen—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000329	0.000578	CcSEcCtD
Baclofen—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000329	0.000578	CcSEcCtD
Baclofen—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000329	0.000577	CcSEcCtD
Baclofen—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.000577	CcSEcCtD
Baclofen—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000328	0.000576	CcSEcCtD
Baclofen—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000328	0.000576	CcSEcCtD
Baclofen—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000328	0.000575	CcSEcCtD
Baclofen—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000327	0.000574	CcSEcCtD
Baclofen—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.000573	CcSEcCtD
Baclofen—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000326	0.000573	CcSEcCtD
Baclofen—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000325	0.000571	CcSEcCtD
Baclofen—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000325	0.000571	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000325	0.00643	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000325	0.00643	CbGpPWpGaD
Baclofen—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000324	0.00057	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000324	0.000569	CcSEcCtD
Baclofen—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000323	0.000568	CcSEcCtD
Baclofen—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000322	0.000566	CcSEcCtD
Baclofen—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000321	0.000565	CcSEcCtD
Baclofen—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.00032	0.000563	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.00032	0.000563	CcSEcCtD
Baclofen—Shock—Ritonavir—acquired immunodeficiency syndrome	0.00032	0.000562	CcSEcCtD
Baclofen—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000319	0.000561	CcSEcCtD
Baclofen—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000319	0.000561	CcSEcCtD
Baclofen—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000319	0.00056	CcSEcCtD
Baclofen—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000319	0.00056	CcSEcCtD
Baclofen—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000318	0.000559	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000318	0.0063	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000318	0.0063	CbGpPWpGaD
Baclofen—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000318	0.000559	CcSEcCtD
Baclofen—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000318	0.000558	CcSEcCtD
Baclofen—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000317	0.000557	CcSEcCtD
Baclofen—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.000557	CcSEcCtD
Baclofen—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000317	0.000557	CcSEcCtD
Baclofen—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000317	0.000556	CcSEcCtD
Baclofen—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000317	0.000556	CcSEcCtD
Baclofen—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000316	0.000555	CcSEcCtD
Baclofen—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000316	0.000554	CcSEcCtD
Baclofen—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000315	0.000554	CcSEcCtD
Baclofen—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000314	0.000552	CcSEcCtD
Baclofen—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.000552	CcSEcCtD
Baclofen—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000314	0.000552	CcSEcCtD
Baclofen—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000314	0.000552	CcSEcCtD
Baclofen—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000314	0.000551	CcSEcCtD
Baclofen—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000313	0.00055	CcSEcCtD
Baclofen—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000313	0.00055	CcSEcCtD
Baclofen—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000313	0.00055	CcSEcCtD
Baclofen—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000312	0.000549	CcSEcCtD
Baclofen—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000312	0.000548	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000311	0.00617	CbGpPWpGaD
Baclofen—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.000547	CcSEcCtD
Baclofen—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000311	0.000547	CcSEcCtD
Baclofen—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000311	0.000546	CcSEcCtD
Baclofen—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00031	0.000545	CcSEcCtD
Baclofen—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00031	0.000544	CcSEcCtD
Baclofen—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000309	0.000544	CcSEcCtD
Baclofen—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000309	0.000543	CcSEcCtD
Baclofen—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000309	0.000543	CcSEcCtD
Baclofen—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000308	0.000541	CcSEcCtD
Baclofen—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000308	0.00054	CcSEcCtD
Baclofen—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000307	0.00054	CcSEcCtD
Baclofen—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000307	0.00054	CcSEcCtD
Baclofen—GABBR2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000307	0.00608	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000307	0.00608	CbGpPWpGaD
Baclofen—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000307	0.000539	CcSEcCtD
Baclofen—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000307	0.000539	CcSEcCtD
Baclofen—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000306	0.000537	CcSEcCtD
Baclofen—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000306	0.000537	CcSEcCtD
Baclofen—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000304	0.000535	CcSEcCtD
Baclofen—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000304	0.000534	CcSEcCtD
Baclofen—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000304	0.000534	CcSEcCtD
Baclofen—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000304	0.000534	CcSEcCtD
Baclofen—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.000534	CcSEcCtD
Baclofen—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.000533	CcSEcCtD
Baclofen—Rash—Stavudine—acquired immunodeficiency syndrome	0.000303	0.000533	CcSEcCtD
Baclofen—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000303	0.000532	CcSEcCtD
Baclofen—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000303	0.000532	CcSEcCtD
Baclofen—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000303	0.000532	CcSEcCtD
Baclofen—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000302	0.000531	CcSEcCtD
Baclofen—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000302	0.000531	CcSEcCtD
Baclofen—Headache—Stavudine—acquired immunodeficiency syndrome	0.000301	0.000529	CcSEcCtD
Baclofen—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000301	0.000529	CcSEcCtD
Baclofen—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000301	0.000529	CcSEcCtD
Baclofen—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.000528	CcSEcCtD
Baclofen—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.000528	CcSEcCtD
Baclofen—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.0003	0.000528	CcSEcCtD
Baclofen—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.0003	0.000527	CcSEcCtD
Baclofen—Rash—Abacavir—acquired immunodeficiency syndrome	0.000299	0.000525	CcSEcCtD
Baclofen—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000299	0.000524	CcSEcCtD
Baclofen—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000298	0.000524	CcSEcCtD
Baclofen—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000298	0.000524	CcSEcCtD
Baclofen—Headache—Abacavir—acquired immunodeficiency syndrome	0.000297	0.000521	CcSEcCtD
Baclofen—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000297	0.000521	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000296	0.00052	CcSEcCtD
Baclofen—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000296	0.00052	CcSEcCtD
Baclofen—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000296	0.00052	CcSEcCtD
Baclofen—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000294	0.000516	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000294	0.00582	CbGpPWpGaD
Baclofen—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000294	0.000516	CcSEcCtD
Baclofen—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000293	0.000514	CcSEcCtD
Baclofen—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.000514	CcSEcCtD
Baclofen—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000292	0.000513	CcSEcCtD
Baclofen—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000292	0.000513	CcSEcCtD
Baclofen—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.00051	CcSEcCtD
Baclofen—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.00029	0.00051	CcSEcCtD
Baclofen—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.00029	0.000509	CcSEcCtD
Baclofen—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.00029	0.000509	CcSEcCtD
Baclofen—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.000509	CcSEcCtD
Baclofen—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000289	0.000508	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000289	0.00572	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000289	0.00572	CbGpPWpGaD
Baclofen—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.000507	CcSEcCtD
Baclofen—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000287	0.000505	CcSEcCtD
Baclofen—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000287	0.000503	CcSEcCtD
Baclofen—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000286	0.000503	CcSEcCtD
Baclofen—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000286	0.000502	CcSEcCtD
Baclofen—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000286	0.000502	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000285	0.000501	CcSEcCtD
Baclofen—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000284	0.0005	CcSEcCtD
Baclofen—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000283	0.000497	CcSEcCtD
Baclofen—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000283	0.000496	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000282	0.00558	CbGpPWpGaD
Baclofen—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000281	0.000494	CcSEcCtD
Baclofen—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000281	0.000493	CcSEcCtD
Baclofen—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.000493	CcSEcCtD
Baclofen—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00028	0.000492	CcSEcCtD
Baclofen—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.000491	CcSEcCtD
Baclofen—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000279	0.00049	CcSEcCtD
Baclofen—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000279	0.00049	CcSEcCtD
Baclofen—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000279	0.00049	CcSEcCtD
Baclofen—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000278	0.000489	CcSEcCtD
Baclofen—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.000488	CcSEcCtD
Baclofen—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000278	0.000488	CcSEcCtD
Baclofen—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.000488	CcSEcCtD
Baclofen—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000278	0.000488	CcSEcCtD
Baclofen—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000276	0.000486	CcSEcCtD
Baclofen—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000275	0.000484	CcSEcCtD
Baclofen—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000275	0.000483	CcSEcCtD
Baclofen—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000272	0.000478	CcSEcCtD
Baclofen—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000272	0.000478	CcSEcCtD
Baclofen—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000474	CcSEcCtD
Baclofen—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.00027	0.000474	CcSEcCtD
Baclofen—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.00027	0.000474	CcSEcCtD
Baclofen—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000268	0.000471	CcSEcCtD
Baclofen—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.000471	CcSEcCtD
Baclofen—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.00047	CcSEcCtD
Baclofen—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.00047	CcSEcCtD
Baclofen—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000266	0.000467	CcSEcCtD
Baclofen—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000266	0.000467	CcSEcCtD
Baclofen—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000266	0.000467	CcSEcCtD
Baclofen—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000266	0.000467	CcSEcCtD
Baclofen—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000265	0.000466	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000265	0.00524	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000265	0.00524	CbGpPWpGaD
Baclofen—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000264	0.000463	CcSEcCtD
Baclofen—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000264	0.000463	CcSEcCtD
Baclofen—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000263	0.000463	CcSEcCtD
Baclofen—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000263	0.000461	CcSEcCtD
Baclofen—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000262	0.00046	CcSEcCtD
Baclofen—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00026	0.000457	CcSEcCtD
Baclofen—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000259	0.000456	CcSEcCtD
Baclofen—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.000454	CcSEcCtD
Baclofen—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.000453	CcSEcCtD
Baclofen—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.000453	CcSEcCtD
Baclofen—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000257	0.000452	CcSEcCtD
Baclofen—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000257	0.000452	CcSEcCtD
Baclofen—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.000451	CcSEcCtD
Baclofen—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000257	0.000451	CcSEcCtD
Baclofen—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000256	0.000449	CcSEcCtD
Baclofen—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000448	CcSEcCtD
Baclofen—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000255	0.000448	CcSEcCtD
Baclofen—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000252	0.000443	CcSEcCtD
Baclofen—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000251	0.000442	CcSEcCtD
Baclofen—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000249	0.000437	CcSEcCtD
Baclofen—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000249	0.000437	CcSEcCtD
Baclofen—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000248	0.000436	CcSEcCtD
Baclofen—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.000434	CcSEcCtD
Baclofen—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000247	0.000434	CcSEcCtD
Baclofen—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000247	0.000434	CcSEcCtD
Baclofen—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.000432	CcSEcCtD
Baclofen—Rash—Indinavir—acquired immunodeficiency syndrome	0.000245	0.000431	CcSEcCtD
Baclofen—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000245	0.00043	CcSEcCtD
Baclofen—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000244	0.000429	CcSEcCtD
Baclofen—Headache—Indinavir—acquired immunodeficiency syndrome	0.000244	0.000428	CcSEcCtD
Baclofen—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000243	0.000427	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000242	0.00479	CbGpPWpGaD
Baclofen—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.00024	0.000422	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000238	0.00472	CbGpPWpGaD
Baclofen—Urticaria—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.000416	CcSEcCtD
Baclofen—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000414	CcSEcCtD
Baclofen—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000236	0.000414	CcSEcCtD
Baclofen—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000234	0.00041	CcSEcCtD
Baclofen—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000233	0.00041	CcSEcCtD
Baclofen—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000232	0.000408	CcSEcCtD
Baclofen—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000232	0.000407	CcSEcCtD
Baclofen—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000231	0.000407	CcSEcCtD
Baclofen—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000231	0.000406	CcSEcCtD
Baclofen—Headache—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.000404	CcSEcCtD
Baclofen—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.00023	0.000404	CcSEcCtD
Baclofen—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000224	0.000394	CcSEcCtD
Baclofen—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.000393	CcSEcCtD
Baclofen—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000222	0.000391	CcSEcCtD
Baclofen—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000222	0.000389	CcSEcCtD
Baclofen—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000221	0.000389	CcSEcCtD
Baclofen—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000221	0.000389	CcSEcCtD
Baclofen—Headache—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.000387	CcSEcCtD
Baclofen—GABBR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00022	0.00435	CbGpPWpGaD
Baclofen—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000218	0.000383	CcSEcCtD
Baclofen—GABBR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000218	0.00432	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000216	0.00429	CbGpPWpGaD
Baclofen—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000215	0.000378	CcSEcCtD
Baclofen—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000214	0.000376	CcSEcCtD
Baclofen—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000214	0.000376	CcSEcCtD
Baclofen—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000211	0.000371	CcSEcCtD
Baclofen—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000209	0.000367	CcSEcCtD
Baclofen—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000207	0.000363	CcSEcCtD
Baclofen—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000207	0.000363	CcSEcCtD
Baclofen—Rash—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00036	CcSEcCtD
Baclofen—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.000205	0.00036	CcSEcCtD
Baclofen—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.000204	0.000359	CcSEcCtD
Baclofen—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000204	0.000358	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000201	0.00399	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000201	0.00397	CbGpPWpGaD
Baclofen—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000199	0.000349	CcSEcCtD
Baclofen—GABBR2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000198	0.00393	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000198	0.00392	CbGpPWpGaD
Baclofen—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000197	0.000347	CcSEcCtD
Baclofen—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000347	CcSEcCtD
Baclofen—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000197	0.000346	CcSEcCtD
Baclofen—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000196	0.000344	CcSEcCtD
Baclofen—GABBR2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000195	0.00387	CbGpPWpGaD
Baclofen—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000193	0.000339	CcSEcCtD
Baclofen—SLC22A8—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	0.000192	0.00381	CbGpPWpGaD
Baclofen—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.00019	0.000333	CcSEcCtD
Baclofen—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.000331	CcSEcCtD
Baclofen—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000188	0.00033	CcSEcCtD
Baclofen—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000187	0.000328	CcSEcCtD
Baclofen—Nausea—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000326	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000181	0.00359	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000181	0.00359	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000177	0.00351	CbGpPWpGaD
Baclofen—Nausea—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000311	CcSEcCtD
Baclofen—GABBR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000171	0.00338	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000171	0.00338	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00013	0.00257	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000128	0.00253	CbGpPWpGaD
Baclofen—GABBR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000126	0.00249	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	0.000117	0.00232	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	0.000114	0.00226	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	0.000105	0.00208	CbGpPWpGaD
Baclofen—GABBR2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	0.000104	0.00207	CbGpPWpGaD
Baclofen—SLC22A8—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.77e-05	0.00193	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.76e-05	0.00134	CbGpPWpGaD
Baclofen—GABBR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.72e-05	0.00133	CbGpPWpGaD
Baclofen—GABBR2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.16e-05	0.00122	CbGpPWpGaD
Baclofen—GABBR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.97e-05	0.000786	CbGpPWpGaD
